Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 19617, 2020 11 12.
Artigo em Inglês | MEDLINE | ID: mdl-33184378

RESUMO

Melanoma is the most aggressive and fatal type of skin cancer due to being highly proliferative. Acetylsalicylic acid (ASA; Aspirin) and salicylic acid (SA) are ancient drugs with multiple applications in medicine. Here, we showed that ASA and SA present anticancer effects against a murine model of implanted melanoma. These effects were also validated in 3D- and 2D-cultured melanoma B16F10 cells, where the drugs promoted pro-apoptotic effects. In both in vivo and in vitro models, SA and ASA triggered endoplasmic reticulum (ER) stress, which culminates with the upregulation of the pro-apoptotic transcription factor C/EBP homologous protein (CHOP). These effects are initiated by ASA/SA-triggered Akt/mTOR/AMPK-dependent activation of nitric oxide synthase 3 (eNOS), which increases nitric oxide and reactive oxygen species production inducing ER stress response. In the end, we propose that ASA and SA instigate anticancer effects by a novel mechanism, the activation of ER stress.


Assuntos
Apoptose/efeitos dos fármacos , Aspirina/farmacologia , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Melanoma/etiologia , Melanoma/patologia , Óxido Nítrico/metabolismo , Ácido Salicílico/farmacologia , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/patologia , Proteínas Quinases Ativadas por AMP/metabolismo , Animais , Antineoplásicos , Aspirina/uso terapêutico , Linhagem Celular Tumoral , Modelos Animais de Doenças , Masculino , Melanoma/tratamento farmacológico , Camundongos Endogâmicos C57BL , Terapia de Alvo Molecular , Óxido Nítrico Sintase Tipo III/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Ácido Salicílico/uso terapêutico , Neoplasias Cutâneas/tratamento farmacológico , Serina-Treonina Quinases TOR/metabolismo , Regulação para Cima/efeitos dos fármacos
2.
Free Radic Biol Med ; 108: 183-191, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28363600

RESUMO

Trypanosoma cruzi is the causative agent of Chagas disease and has a single mitochondrion, an organelle responsible for ATP production and the main site for the formation of reactive oxygen species (ROS). T. cruzi is an obligate intracellular parasite with a complex life cycle that alternates between vertebrate and invertebrate hosts, therefore the development of survival strategies and morphogenetic adaptations to deal with the various environments is mandatory. Over the years our group has been studying the vector-parasite interactions using heme as a physiological oxidant molecule that triggered epimastigote proliferation however, the source of ROS induced by heme remained unknown. In the present study we demonstrate the involvement of heme in the parasite mitochondrial metabolism, decreasing oxygen consumption leading to increased mitochondrial ROS and membrane potential. First, we incubated epimastigotes with carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP), an uncoupler of oxidative phosphorylation, which led to decreased ROS formation and parasite proliferation, even in the presence of heme, correlating mitochondrial ROS and T. cruzi survival. This hypothesis was confirmed after the mitochondria-targeted antioxidant ((2-(2,2,6,6 Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) triphenylphosphonium chloride (MitoTEMPO) decreased both heme-induced ROS and epimastigote proliferation. Furthermore, heme increased the percentage of tetramethylrhodamine methyl ester (TMRM) positive parasites tremendously-indicating the hyperpolarization and increase of potential of the mitochondrial membrane (ΔΨm). Assessing the mitochondrial functional metabolism, we observed that in comparison to untreated parasites, heme-treated epimastigotes decreased their oxygen consumption, and increased the complex II-III activity. These changes allowed the electron flow into the electron transport system, even though the complex IV (cytochrome c oxidase) activity decreased significantly, showing that heme-induced mitochondrial ROS appears to be a consequence of the enhanced mitochondrial physiological modulation. Finally, the parasites that were submitted to high concentrations of heme presented no alterations in the ultrastructure. Consequently, our results suggest that heme released by the insect vector after the blood meal, modify epimastigote mitochondrial physiology to increase ROS as a metabolic mechanism to maintain epimastigote survival and proliferation.


Assuntos
Doença de Chagas/imunologia , Heme/metabolismo , Mitocôndrias/metabolismo , Trypanosoma cruzi/fisiologia , Animais , Carbonil Cianeto p-Trifluormetoxifenil Hidrazona/metabolismo , Processos de Crescimento Celular , Células Cultivadas , Transporte de Elétrons , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Metabolismo Energético , Humanos , Estágios do Ciclo de Vida , Potencial da Membrana Mitocondrial , Compostos Organofosforados/metabolismo , Consumo de Oxigênio , Piperidinas/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Rodaminas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...